Alkem Laboratories Ltd. benchmarking: Performance to industry peers

Financial

	Alkem Laboratories	Glenmark Pharma.	Abbott India
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	192.0 .	13.0 .	n/a
Number of ANDA's Approved By USFDA	167.0 .	25.0 .	n/a
Number of ANDA's Filed in Europe	18.0	n/a	n/a
Number of ANDA's Approved in Europe	12.0	n/a	n/a
Number of ANDA's Filed in Australia	42.0	n/a	n/a
Number of ANDA's Approved by Australia	32.0	n/a	n/a
Domestic Sales Growth - YoY	10.0 %	13.7 %	6.5 %
R&D as a % of Total Sales	6.4 %	7.3 %	0.02 %
Financials
5 yr Average ROE	17.38 %	7.81 %	30.11 %
5yr average Equity Multiplier	1.39	1.78	1.43
5yr Average Asset Turnover Ratio	0.86	0.8	1.14
5yr Avg Net Profit Margin	14.54 %	2.85 %	18.53 %
Price to Book	4.84	6.19	12.25
P/E	29.08	47.77	37.68
5yr Avg Cash Conversion Cycle	-61.46 Days	-150.94 Days	-46.68 Days
Inventory Days	56.11 Days	32.28 Days	45.22 Days
Days Receivable	44.62 Days	32.34 Days	19.34 Days
Days Payable	122.42 Days	201.14 Days	109.21 Days
5yr Average Interest Coverage Ratio	24.48	4.25	97.37
5yr Avg ROCE	22.76 %	17.54 %	38.77 %
5yr Avg Operating Profit Margin	18.44 %	15.96 %	23.42 %
5 yr average Debt to Equity	0.18	0.38	0.0
5yr CAGR Net Profit	6.44 %	1.54 %	95.4 %
5yr Average Return on Assets	12.47 %	2.09 %	21.03 %
Shareholdings
Promoter Holding	49.7 %	46.65 %	74.99 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-7.46 %	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	5.26 %	11.37 %	0.8 %

Business

	Alkem Laboratories	Glenmark Pharma.	Abbott India
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Glenmark Pharma (Branded generics) 0 Glenmark generics 0 Vitamin, Minerals & Nutrition 0 Hepatoprotectives 0 Hormones 0 Anti Diabetic 0 Central Nervous System 0 Respiratory 0 Vaccines 0 cardiovascular system 0 Derma 0 Anti-Infectives 0 Metabolic 0 Women`s health 0 Gastro Intestinal 0 Pain 0	Product Wise Break-Up Vaccines 0 Central Nervous System 0 Gastro Intestinal 0 Derma 0 Metabolic 0 cardiovascular system 0 Pain 0 Hormones 0 Hepatoprotectives 0 Respiratory 0 Women`s health 0 Anti-Infectives 0 Pharmaceutical 0 Vitamin, Minerals & Nutrition 0 Anti Diabetic 0 Formulations 39.54 Branded Generics 60.46	Product Wise Break-Up Vaccines 0 Central Nervous System (CNS) 12.65 Gastro Intestinal 25.46 Derma 0 Metabolic 0 cardiovascular system 0 Pain 0 Hormones 11.59 Hepatoprotectives 0 Respiratory 0 Women`s health 0 Anti-Infectives 0 Pharmaceutical 0 Vitamin, Minerals & Nutrition 0 Anti Diabetic 42.82 Glenmark generics 0 Glenmark Pharma (Branded generics) 0 Others 7.48
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Anti-Infective 33.8 Gastro Intestinal 21.2 Vitamins / Minerals / Nutrients 12.0 Pain Management 10.1 Anti - Diabetes 5.0 Gynecology 4.1 Central Nervous System (CNS) 3.7 Respiratory 3.0 Derma 2.4 Cardiac Science 2.3 Others 2.4	-	-
Location Wise Break-Up	Location Wise Break-Up India 65.5 USA 34.5 Rest of the World 0 Europe 0 Latin America 0 North America 0	Location Wise Break-Up USA 0 North America 24.77 Rest of the World 24.05 Latin America 0 Europe 23.86 India 27.32	Location Wise Break-Up USA 0 North America 0 Rest of the World 1.19 Latin America 0 Europe 0 India 98.81
Asset Break-Up	Asset Break-Up India 70.19 USA 28.27 Rest of the World 0 Europe 0 Latin America 0 North America 0 Others 1.54	Asset Break-Up USA 0 North America 42.56 Rest of the World 4.94 Latin America 0 Europe 3.09 India 49.4 Others 0.01	-

Alkem Laboratories Ltd.

Alkem Laboratories Ltd.

Financial

Business

SIGN UP FOR FREE